Orange Book product · Generic (ANDA)
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
At a glance
Nov 17, 2023
Approved
Generic (ANDA)
Application
AA
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 17, 2023
2 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Strength
66%;10%
Dosage form
SOLUTION
Route
ORAL, RECTAL
TE code
AA
Application
ANDA 215049
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
- 1989MD-76RBrand (NDA)
NDA 019292 · LIEBEL-FLARSHEIM
- —HYPAQUE-M,75%Brand (NDA)
NDA 010220 · GE HEALTHCARE
- —RENOGRAFIN-60Brand (NDA)
NDA 010040 · BRACCO
- —GASTROGRAFINBrand (NDA)
NDA 011245 · BRACCO
- 2022DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUMGeneric (ANDA)
ANDA 214201 · ANDA REPOSITORY
- 1988RENOCAL-76Generic (ANDA)
ANDA 089347 · BRACCO
- 1983DIATRIZOATE-60Generic (ANDA)
ANDA 088166 · INTL MEDICATION
- 1982ANGIOVIST 292Generic (ANDA)
ANDA 087724 · BAYER HLTHCARE
- 1982ANGIOVIST 370Generic (ANDA)
ANDA 087723 · BAYER HLTHCARE
- 1982GASTROVISTGeneric (ANDA)
ANDA 087728 · BAYER HLTHCARE
- —HYPAQUE-76Generic (ANDA)
ANDA 086505 · GE HEALTHCARE
- —MD-60Generic (ANDA)
ANDA 087074 · MALLINCKRODT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
